Home › Trials › NCT06714344
Clinical trial Recruiting at 2 sites Interventional Ages 18 and up

Improving physician adherence in heart failure treatment

Official title: A Prospective Open Randomised Trial to Test the Efficacy of an Assisted Therapy

Run by Medical University Innsbruck · NCT06714344 · Data updated 2026-11-12

This study is testing a new support program to help doctors follow heart failure treatment guidelines better, to see if it can improve patients' health and reduce hospital visits.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment234 (estimated)
SponsorMedical University Innsbruck
Academic / other
Locations2 sites (Graz, Styria and 1 other locations)
StatusRecruiting
StartedDecember 3, 2024
Main results expectedSeptember 30, 2027
Study endsSeptember 30, 2027
Registry record updatedFebruary 19, 2025
Trial IDNCT06714344 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults over 18 years old who have been hospitalized for decompensated heart failure and require intravenous diuretics.

Probably not a fit

Patients with multimorbidity, dementia, or those unwilling to participate may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of an Assisted Therapy Optimizing Module designed to enhance physician adherence to guideline-directed medical therapy (GDMT) for heart failure patients. It is a prospective, randomized, multi-sectoral, multi-centre study with a parallel group design. The intervention aims to support network physicians in implementing GDMT, which is often underutilized, particularly in patients enrolled in the telemedicine-supported Herzmobil Tirol program. By improving adherence to GDMT, the study seeks to enhance patient outcomes, including quality of life and reduced hospitalizations.

Why it matters

Potential benefit: If successful, this approach could significantly improve the management of heart failure, leading to better patient outcomes and reduced hospitalizations.

How similar studies have gone: Other studies have shown success in improving adherence to treatment guidelines in chronic conditions, suggesting potential for this approach in heart failure management.

Who can join: the full rules

Show full inclusion / exclusion criteria 
Inclusion Criteria:

AMPEL, CIP, Version: 1.2 Date: 27.03.2024

1. Written, signed and dated informed consent for inclusion in the HM programme
2. Male and female patients over 18 years of age.
3. Hospitalised for decompensated heart failure requiring intravenous diuretics
4. Need for iv diuresis in nonhospital setting because of impending hospitalization for cardiac decompensation

Exclusion Criteria:

1. Multimorbidity (Charlson Comorbidity Index \> 6)
2. Dementia
3. Lack of willingness to participate

Where it's running

  • Medical University of Graz, University Hospital for Internal Medicine (Cardiology)
    Graz, Styria, Austria     Recruiting
  • Medical University of Innsbruck, University Hospital for Internal Medicine III (Cardiology and Angiology)
    Innsbruck, Tyrol, Austria     Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
View on ClinicalTrials.gov ↗ Find more trials like this →
Browse more
Heart Failure 1020Medical University Innsbruck 35
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.